Search
healthcare › ... › additional-services
… patients and those with special needs, to make your visit easier. Currently, we offer assistance in securing …
research › ... › alumni
… role of plant H+-ATPases in TORC1 regulation. During my free time, I love reading, doing exercise (outdoors if the … particular plant small RNA, MIR2911, which is derived from 26S rRNA, is abundant in most plant foods and is … start my molecular fellowship in Cleveland clinic. In my free time, I play soccer (I take it way too seriously-but …
research › ... › neurobehavior
… for and use of the core facilities is currently available free of charge to all BCM investigators. When requesting …
departments › ... › tropical-medicine
… of Tropical Medicine and the Division of Tropical Medicine. Visit the NSTM public policy page for information. …
research › ... › mcnair-scholars-program
… McNair Scholar Dr. Bing Zhang and his team have revealed a more comprehensive view of colon …
healthcare › clinical-trials › h-46822
… + T-DM1. Both tucatinib and T-DM1 are approved by the FDA for the treatment of breast cancer. … HER2CLIMB-02: Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T-DM1) for Patients with HER2-positive Breast Cancer …
healthcare › clinical-trials › h-45373
… depending on the patient's prior induction treatment. For more information: https://clinicaltrials.gov/ct2/show/NCT03926624 . … Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd Salvage (D18-11141) …
healthcare › clinical-trials › h-54903
… Non-Transplant-Eligible Patients With Relapsed/Refractory Large B-Cell Lymphoma … how well these combinations work in treating patients with large B-cell lymphoma that returned or did not respond to … S2207: Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to …
healthcare › ... › dysphagia
… provide a comprehensive, multidisciplinary approach with a team of otolaryngologists, thoracic surgeons, …